Direkt zum Inhalt
Merck
Alle Fotos(1)

Key Documents

View All Documentation

47317

Sigma-Aldrich

Fmoc-Lys(Fmoc)-OH

≥98.0% (HPLC)

Synonym(e):

Nα,Nε-di-Fmoc-L-lysin

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C36H34N2O6
CAS-Nummer:
78081-87-5
Molekulargewicht:
590.66
Beilstein:
6034060
MDL-Nummer:
MFCD00080275
UNSPSC-Code:
12352209
PubChem Substanz-ID:
57650922
NACRES:
NA.26

Assay

≥98.0% (HPLC)

Eignung der Reaktion

reaction type: Fmoc solid-phase peptide synthesis

Anwendung(en)

peptide synthesis

Funktionelle Gruppe

Fmoc

Lagertemp.

2-8°C

SMILES String

OC(=O)[C@H](CCCCNC(=O)OCC1c2ccccc2-c3ccccc13)NC(=O)OCC4c5ccccc5-c6ccccc46

InChI

1S/C36H34N2O6/c39-34(40)33(38-36(42)44-22-32-29-17-7-3-13-25(29)26-14-4-8-18-30(26)32)19-9-10-20-37-35(41)43-21-31-27-15-5-1-11-23(27)24-12-2-6-16-28(24)31/h1-8,11-18,31-33H,9-10,19-22H2,(H,37,41)(H,38,42)(H,39,40)/t33-/m0/s1

InChIKey

BMJRTKDVFXYEFS-XIFFEERXSA-N

Verwandte Kategorien

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

Eyeshields, Gloves, type N95 (US)

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number
BCBW9055
BCBF8531V
BCBT4641
BCBR8529V
BCBM7845V

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Suche nach COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Joseph R Merrill et al.
Biomaterials, 84, 241-249 (2016-02-04)
Tumor angiogenesis, the formation of new tumor blood supply, has been recognized as a hallmark of cancer and represents an important target for clinical management of various angiogenesis-dependent solid tumors. Previously, by screening a bacteriophage peptide library we have discovered
Shafq Al-Azzawi et al.
International journal of molecular sciences, 19(10) (2018-10-21)
Alzheimer's disease (AD) is a progressive brain disorder and age-related disease characterised by abnormal accumulation of β-amyloid (Aβ). The development of drugs to combat AD is hampered by the lack of therapeutically-active molecules able to cross the blood-brain barrier (BBB).
Alex Abramov et al.
Molecules (Basel, Switzerland), 24(1) (2018-12-24)
In this work we have investigated the potential benefits of using supramolecular gel networks as reaction media to carry out air-sensitive metal-free light-induced trifluoromethylation of six-membered (hetero)arenes under aerobic conditions. This reaction was performed at room temperature (RT) using sodium
Andrew G Cheetham et al.
Acta pharmacologica Sinica, 38(6), 874-884 (2017-03-07)
The conjugation of small molecular hydrophobic anticancer drugs onto a short peptide with overall hydrophilicity to create self-assembling drug amphiphiles offers a new prodrug strategy, producing well-defined, discrete nanostructures with a high and quantitative drug loading. Here we show the
Martina Tripepi et al.
Bioconjugate chemistry, 29(4), 1428-1437 (2018-02-23)
Molecular imaging requires the specific accumulation of contrast agents at the target. To exploit the superb resolution of MRI for applications in molecular imaging, gadolinium chelates, as the MRI contrast agents (CA), have to be conjugated to a specific vector
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.